CONTACK RENEWAL IS1/DR1 CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)

Cardiac related image

A Cardiac Resynchronization Therapy Defibrillator (CRT-D) Related Image

(Not Necessarily related to the device)

Description:

CONTACK RENEWAL IS1/DR1 Cardiac Resynchronization Therapy Defibrillator (CRT-D) by Boston Scientific Corp.

The CONTACK RENEWAL IS1/DR1 CRT-D is a cutting-edge medical device designed by Boston Scientific Corp. It plays an instrumental role in effectively managing heart rhythm disorders such as heart failure or arrhythmias. Its features stem from the innovative technological advancements made in the field of cardiac resynchronization therapy.

This revolutionary device is primarily used for detecting and correcting irregular heart rhythms by delivering minor electric shocks. In essence, the CONTACK RENEWAL IS1/DR1 CRT-D can help many patients resume a normal lifestyle by improving their heart's efficiency and overall functionality.

The primary benefits of the CONTACK RENEWAL IS1/DR1 CRT-D include:

Constant monitoring and automated adjustment of heart rhythms.
Enhanced patient safety by providing instantaneous response to irregular heartbeats.
Improved longevity and quality of life for patients suffering from heart disorders.
Reduced hospitalization rates by effectively managing heart conditions and reducing the risk of sudden cardiac arrest.

With Boston Scientific Corp.'s strong emphasis on quality assurance and innovative design, the CONTACK RENEWAL IS1/DR1 CRT-D is a reliable and proven solution for facilitating effective cardiac resynchronization therapy.

Primary Use:

INTRODUCTION

Contak Renewal IS1/DR1 Cardiac Resynchronization Therapy Defibrillator (CRT-D) is a state-of-the-art medical device with one primary purpose: enhancing the overall cardiac health of individuals who suffer from specific heart conditions.

PRIMARY USE OF THE CONTAK RENEWAL CRT-D

The Contak Renewal IS1/DR1 CRT-D device is primarily utilized in Cardiac Resynchronization Therapy (CRT). The principal role of this device revolves around its ability to emit electrical impulses that bedirectly delivered to the lower chambers, or ventricles, of the heart. Ultimately, this promotes a synchronized, effective, and efficient heartbeat. Key advantages of this high-precision device are its ability to detect life-threatening heart rhythms and interv

How It Works:

Overview

The CONTAK RENEWAL IS1/DR1 Cardiac Resynchronization Therapy Defibrillator (CRT-D) is a sophisticated medical device designed to ameliorate symptoms and improve the life quality of patients suffering from certain heart rhythm disorders. This implanted device falls under the category of Cardiac Rhythm Management Devices.

Functionality

The CONTAK RENEWAL IS1/DR1 CRT-D operates in several critical ways to manage cardiac rhythm effectively. First, it tracks the heart's electrical activity, detecting any instances of irregular rhythms, specifically in patients with conditions like heart failure or dilated cardiomyopathy, where both lower chambers or ventricles may beat out of sync. This state, known as dysynchrony, can severely impact cardiac efficiency and overall patient health. Cardiac Resynchronization
The primary role of the device is to resolve this dysynchrony. It uses electrical pulses to stimulate both ventricles simultaneously, ensuring they pump in unison. This process, known as Cardiac Resynchronization Therapy (CRT), can bolster the heart’s efficiency and improve symptoms of heart failure. Defibrillator
Besides, the CONTAK RENEWAL IS1/DR1 CRT-D is also equipped with a defibrillator component. In heart rhythms that are dangerously rapid or chaotic, potential precursors to sudden cardiac arrest, the device delivers a high-energy electrical shock. This shock, known as defibrillation, cuts the dangerous rhythm short and allows the heart's natural pacemaking centers to reestablish a normal rhythm.

Conclusion

In summary, the CONTAK RENEWAL IS1/DR1 CRT-D is a dual-function device – it supplements the natural rhythm by promoting synchronous ventricular contractions and protects against potential life-threatening arrhythmias through defibrillation. This incredibly advanced technology plays a crucial role in managing cardiac rhythm disorders, enabling patients to lead healthier, more productive lives.

Manufacturer:

Boston Scientific Corp.

Status: In Stock

Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.